The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication

@inproceedings{Hooper2015TheSW,
  title={The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication},
  author={Clare Hooper and I D Lyburn and Jeff Searle and Michele M Darby and Tiffany Hall and Dolly L Hall and Anna. Morley and Patrick White and Najib M Rahman and Emma de Winton and Amelia O Clive and V Masani and David T. Arnold and Adam Dangoor and Samir Guglani and Paulina Jankowska and Stefanie Lowndes and John E Harvey and Jeremy P. Braybrooke and Nick A Maskell},
  booktitle={British Journal of Cancer},
  year={2015}
}
Background:Robust markers that predict prognosis and detect early treatment response in malignant pleural mesothelioma (MPM) would enhance patient care.Methods:Consecutive patients with MPM who were considered fit for first-line chemotherapy were prospectively recruited. Patients of similar performance status opting for best supportive care were included as a comparator group. Baseline and interval CT, PET-CT and serum markers (mesothelin, fibulin-3 and neutrophil–lymphocyte ratio (NLR)) were… CONTINUE READING
Highly Cited
This paper has 22 citations. REVIEW CITATIONS
13 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Fibulin-3 as a blood

  • HI Pass, SM Levin, +13 authors C Goparaju
  • 2012
3 Excerpts

Similar Papers

Loading similar papers…